Pharmacokinetics of Moxalactam in Subjects With Various Degrees of Renal Dysfunction.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.18.6.933
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacokinetics of Ceftizoxime in Subjects With Various Degrees of Renal Function.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1983English

Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients With Various Degrees of Renal Function

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Pharmacokinetics of Intravenous Amdinocillin in Healthy Subjects and Patients With Renal Insufficiency.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects With Normal or Varying Degrees of Impaired Renal Function

Drugs in R and D
Pharmacology
2014English

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment

Journal of Clinical Pharmacology
Pharmacology
2015English

Cefazolin and Moxalactam Pharmacokinetics After Simultaneous Intravenous Infusion.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy